Summary
In a prospective clinical trial lasting one year, 35 postmenopausal women with severe climacteric symptoms were cyclically treated with conjugated oestrogens (1.25 mg daily). This oestrogen replacement therapy was randomly supplemented with 10 mg of megestrol acetate daily (18 women) or 50 mg of clomiphene citrate (17 women) for 10 days four times a year. Both treatment regimens significantly alleviated climacteric symptoms. At the end of the oestrogen-megestrol acetate treatment no endometrial proliferation or hyperplasia was seen, while at the end of the oestrogen-clomiphene citrate treatment the endometrium was proliferative or hyperplastic in two women and atrophic in the other 15. Regular uterine bleeding occurred in each woman after megestrol acetate but never after clomiphene citrate administration. Break-through bleeding during the oestrogen treatment periods appeared in the megestrol and clomiphene groups in five and eight women, respectively. There were no clinically adverse hormonal or metabolic changes during megestrol acetate or clomiphene citrate treatment periods.
Our results provide further evidence that in addition to progestins postmenopausal oestrogen replacement therapy can safely be supplemented with antioestrogen and thereby avoid the bleeding which occurs regularly after progestin withdrawal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexieva-Figusch J, van Gilse HA, Hop WCJ, Phoa CH, Blonk VD, Wijst J, Treurniet RE (1980) Progestin therapy in advanced breast cancer. Megestrol acetate — an evaluation of 160 treated cases. Cancer 46: 2369–2372
Cambell S (1976) Double-blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: Cambell S (ed) The management of the menopause and postmenopausal years. MTP Press, Lancaster, pp 149–158
Erlik Y, Meldrum DR, Lagasse LD, Judd HL (1981) Effect of megestrol acetate on flushing and bone metabolism in post-menopausal women. Maturitas 3: 167–172
Gambrell RD (1979) The role of hormones in the etiology of breast and endometrial cancer. Acta Obstet Gynecol Scand 88: 73–81
Geisler HE (1973) The use of megestrol acetate in the treatment of advanced lesions of the endometrium. Gynecol Oncol 1: 340–344
Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT (1979) Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol 133: 537–547
Hammond GL, Kontturi M, Määttälä P, Vihko R (1977a) Serum FSH, LH and prolactin in normal males and patients with prostatic disease. Clin Endocrinol 7: 129–135
Hammond GL, Viinikka L, Vihko R (1977b) Automation of radioimmunoassays for some sex steroids with use of both iodinated and tritiated ligands. Clin Chem 23: 1250–1257
Hulka BS, Grimson RC, Greenberg BG, Kaufman DG, Fowler WC Jr, Hogue CJR, Berger GS, Pulliam CC (1980) “Alternative” controls in a case-control study of endometrial cancer and exogenous estrogen. Am J Epidemiol 112: 376–387
Kauppila A, Jänne O, Kivinen S, Kokko E, Lantto T, Tuimala R, Vihko R (1981) Postmenopausal hormone replacement therapy with estrogen periodically supplemented with antiestrogen. Am J Obstet Gynecol 140: 787–792
Kokko E, Jänne O, Kauppila A, Vihko R (1981) Cyclic clomiphene treatment lowers cytosol estrogen and progestin receptor concentrations in the endometrium of postmenopausal women on estrogen replacement therapy. J Clin Endocrinol Metab 52: 345–349
Kupperman HS, Wetchler BB, Blatt MCH (1959) Contemporary therapy of menopausal syndrome. JAMA 171: 1627–1637
Lind T, Cameron EC, Hunter WM, Leon C, Moran PF, Oxley A, Gerrard J, Lind UCG (1979) A prospective controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol [Suppl] 86: 1–29
Patterson JS, Battersby LA (1980) Tamoxifen: An overview of recent studies in the field of oncology. Cancer Treat Rep 64: 775–778
Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A (1979) Lipid metabolic studies in oophorectomized women. Effects of three different progestagen. Acta Obstet Gynecol Scand [Suppl] 88: 89–95
Sturdee DW, Wade-Evans T, Paterson MEL, Thom M, Studd IWW (1978) Relations between bleeding patterns, endometrial histology and oestrogen treatment in menopausal women. Br Med J I: 1575–1577
Thom MH, While PJ, Sturdee DW, Paterson MEL, Wade-Evans T, Studd JWW (1979) Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet II: 455–457
Tikkanen MJ, Nikkilä EA, Vartiainen E (1978) Natural oestrogen as an effective treatment for type-II hyper-lipoproteinaemia in postmenopausal women. Lancet II: 490–491
Wall JA, Franklin RE, Kaufman RH (1964) Reversal of benign and malignant endometrial changes with clomiphene. Am J Obstet Gynecol 88: 1072–1085
Whitehead MI, Townsend PT, Pryse-Davies J, Path FRC, Ryder TA, King RJ (1981) Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 305: 1599–1605
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Finnish Cancer Foundation, Helsinki, Finland
Rights and permissions
About this article
Cite this article
Kauppila, A., Kivinen, S., Leinonen, P. et al. Comparison of megestrol acetate and clomiphene citrate as supplemental medication in postmenopausal oestrogen replacement therapy. Arch. Gynecol. 234, 49–58 (1983). https://doi.org/10.1007/BF02114725
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02114725